Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03820830
Title Palbociclib for HR Positive / HER2-negative Isolated Locoregional Recurrence of Breast Cancer (POLAR)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors International Breast Cancer Study Group
Indications

Her2-receptor negative breast cancer

Therapies

Anastrozole

Exemestane

Anastrozole + Palbociclib

Letrozole

Letrozole + Palbociclib

Exemestane + Palbociclib

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | AUT


No variant requirements are available.